v3.25.4
Equity Method and Other Investments - Additional Information (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Equity Method Investment income from equity method investments        
Equity investment income (loss) from equity method investments in nonconsolidated dialysis partnerships.   $ 33,000 $ 26,189 $ 27,864
Other loss, net   $ (102,688) (69,808) (19,177)
Mozarc Medical Holding LLC        
Equity Method Investment income from equity method investments        
Equity method investment, significant impairments and other valuation adjustments $ 73,559      
Other loss, net $ 12,641      
Minimum | Company and Restricted Subsidiaries        
Equity Method Investment income from equity method investments        
Ownership percentage by the Company 25.00% 25.00%    
Maximum | Company and Restricted Subsidiaries        
Equity Method Investment income from equity method investments        
Ownership percentage by the Company 65.00% 65.00%    
Other Nonoperating Income (Expense)        
Equity Method Investment income from equity method investments        
Equity method investment, significant impairments and other valuation adjustments   $ 0    
Equity investment income (loss) from other equity method investments   (139,192) (112,696) (59,508)
Equity Method Investments In Nonconsolidated Dialysis Partnerships        
Equity Method Investment income from equity method investments        
Equity investment income (loss) from equity method investments in nonconsolidated dialysis partnerships.   $ 33,000 $ 26,189 $ 27,864
Number of equity method investments 19 19